Inventor · disambiguated record
Cory M. Hogaboam
Also filed as: HOGABOAM CORY · HOGABOAM CORY M
8 granted patents·12 pending applications·69 citations·filing 2000–2024
84Inventor score
Files withUNIV MICHIGAN REGENTS6UNIV MICHIGAN3LUNG THERAPEUTICS INC2BUNTING RACHEL1CEDARS SINAI MEDICAL CENTER1
Top patents by PatentIndex Score
20 records- 0187US6719969B1Treatment of liver disease and injury with CXC chemokinesUNIV MICHIGAN·Filed 2000·Granted Apr 13, 2004·47 cites·51 claims
- 0284US2025042986A1Stem cell factor inhibitorUNIV MICHIGAN REGENTS·Filed 2024·Application pending·0 cites
- 0382US10501535B2Antibody targeting stem cell factorUNIV MICHIGAN REGENTS·Filed 2016·Granted Dec 10, 2019·2 cites·7 claims
- 0480US9353178B2Stem cell factor inhibitorUNIV MICHIGAN·Filed 2013·Granted May 31, 2016·4 cites·11 claims
- 0580US8911729B2Stem cell factor inhibitorLUKACS NICHOLAS W·Filed 2012·Granted Dec 16, 2014·7 cites·39 claims
- 0675US7541040B2Chimeric molecule for the treatment of th2-like cytokine mediated disordersUS HEALTH·Filed 2002·Granted Jun 2, 2009·9 cites·18 claims
- 0775US2022017613A1Stem cell factor inhibitorUNIV MICHIGAN REGENTS·Filed 2021·Application pending·0 cites
- 0865US2020255509A1Therapeutic antibodies and uses thereofUNIV MICHIGAN REGENTS·Filed 2019·Application pending·0 cites
- 0961US2015018408A1Therapeutic antibodies and uses thereofUNIV MICHIGAN·Filed 2014·Application pending·0 cites
- 1059US2018030129A1Stem cell factor inhibitorUNIV MICHIGAN REGENTS·Filed 2017·Application pending·0 cites
- 1158US9790272B2Stem cell factor inhibitorUNIV MICHIGAN REGENTS·Filed 2016·Granted Oct 17, 2017·0 cites·15 claims
- 1256US2025041383A1Modified caveolin-1 peptides for the treatment of post-acute covid-19LUNG THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1355US2025076312A1Biomarkers for the treatment of interstitial lung diseaseLUNG THERAPEUTICS LLC·Filed 2022·Application pending·0 cites
- 1454US2025262273A1Modified caveolin-1 peptides for the treatment of chronic kidney diseaseREIN THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1552US2023226149A1Modified caveolin-1 peptides for the treatment of pathogen-induced lung injuryLUNG THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1650US2004132657A1Method of treating allergen induced airway diseaseFiled 2003·Application pending·0 cites
- 1746US8795668B2Methods for treating pulmonary fibrosisHOGABOAM CORY M·Filed 2006·Granted Aug 5, 2014·0 cites·23 claims
- 1841US2014141459A1Pentraxin 3 association with asthmaBUNTING RACHEL·Filed 2012·Application pending·0 cites
- 1939US11397178B2Method of predicting progression of idiopathic pulmonary fibrosis and monitoring of therapeutic efficacyCEDARS SINAI MEDICAL CENTER·Filed 2017·Granted Jul 26, 2022·0 cites·14 claims
- 2035US2012282276A1Biomarkers predictive of progression of fibrosisHOGABOAM CORY·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Cory M. Hogaboam files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →